Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Jan-23 8:55 PM View:  | Nabriva Therapeutics Plc (NBRV) | 29-Jan-23 | Payment of Exercise | 431 | $1.50 | $646.50 | (3%) 12.42K to 11.99K | |
| 10-Jan-23 5:56 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jan-23 | Payment of Exercise | 11 | $1.30 | $14.30 | (< 1%) 12.43K to 12.42K | |
| 04-Jan-23 6:09 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Dec-22 | Payment of Exercise | 5 | $1.89 | $9.45 | (< 1%) 12.44K to 12.43K | |
| 08-Dec-22 4:34 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Dec-22 | Payment of Exercise | 9 | $2.02 | $18.18 | (< 1%) 12.45K to 12.44K | |
| 02-Dec-22 5:15 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Nov-22 | Payment of Exercise | 5 | $2.25 | $11.25 | (< 1%) 12.45K to 12.45K | |
| 08-Nov-22 5:24 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Nov-22 | Payment of Exercise | 10 | $2.24 | $22.39 | (< 1%) 12.46K to 12.45K | |
| 01-Nov-22 5:08 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Oct-22 | Payment of Exercise | 5 | $2.54 | $12.70 | (< 1%) 12.46K to 12.46K | |
| 11-Oct-22 5:03 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Oct-22 | Payment of Exercise | 9 | $2.72 | $24.48 | (< 1%) 12.47K to 12.46K | |
| 04-Oct-22 9:31 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Sep-22 | Payment of Exercise | 5 | $2.08 | $10.40 | (< 1%) 12.48K to 12.47K | |
| 07-Sep-22 6:00 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Sep-22 | Payment of Exercise | 225 | $0.16 | $35.24 | (< 1%) 312.2K to 311.98K | |
| 01-Sep-22 6:38 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Aug-22 | Payment of Exercise | 107 | $0.16 | $17.61 | (< 1%) 312.31K to 312.2K | |
| 08-Aug-22 5:44 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Aug-22 | Payment of Exercise | 225 | $0.18 | $41.56 | (< 1%) 312.53K to 312.31K | |
| 03-Aug-22 9:45 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jul-22 | Payment of Exercise | 107 | $0.18 | $19.15 | (< 1%) 312.64K to 312.53K | |
| 07-Jul-22 4:11 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jul-22 | Payment of Exercise | 225 | $0.18 | $40.99 | (< 1%) 312.87K to 312.64K | |
| 01-Jul-22 6:08 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Jun-22 | Payment of Exercise | 107 | $0.18 | $19.47 | (< 1%) 312.97K to 312.87K | |
| 07-Jun-22 4:47 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jun-22 | Payment of Exercise | 225 | $0.20 | $45.00 | (< 1%) 313.2K to 312.97K | |
| 02-Jun-22 4:10 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-May-22 | Payment of Exercise | 107 | $0.21 | $22.11 | (< 1%) 313.31K to 313.2K | |
| 09-May-22 6:32 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-May-22 | Payment of Exercise | 225 | $0.26 | $58.50 | (< 1%) 313.53K to 313.31K | |
| 03-May-22 4:59 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Apr-22 | Payment of Exercise | 107 | $0.31 | $33.17 | (< 1%) 313.64K to 313.53K | |
| 08-Apr-22 4:16 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Apr-22 | Payment of Exercise | 219 | $0.41 | $89.79 | (< 1%) 313.86K to 313.64K | |
| 04-Apr-22 6:27 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Mar-22 | Payment of Exercise | 104 | $0.42 | $43.68 | (< 1%) 313.96K to 313.86K | |
| 08-Mar-22 4:12 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Mar-22 | Payment of Exercise | 263 | $0.43 | $113.09 | (< 1%) 314.22K to 313.96K | |
| 02-Mar-22 7:51 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Feb-22 | Payment of Exercise | 125 | $0.45 | $56.25 | (< 1%) 314.35K to 314.22K | |
| 08-Feb-22 4:25 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Feb-22 | Payment of Exercise | 263 | $0.48 | $126.24 | (< 1%) 314.61K to 314.35K | |
| 01-Feb-22 8:47 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jan-22 | Payment of Exercise | 125 | $0.48 | $60.00 | (< 1%) 314.74K to 314.61K | |
| 01-Feb-22 8:47 PM View: | Nabriva Therapeutics Plc (NBRV) | 29-Jan-22 | Payment of Exercise | 10,766 | $0.45 | $4,844.70 | (3%) 325.5K to 314.74K | |
| 10-Jan-22 4:19 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jan-22 | Payment of Exercise | 270 | $0.58 | $156.60 | (< 1%) 325.77K to 325.5K | < 1% |
| 04-Jan-22 5:06 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Dec-21 | Payment of Exercise | 107 | $0.60 | $64.20 | (< 1%) 325.88K to 325.77K | (23%) |
| 29-Dec-21 9:32 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Dec-21 | Market Purchase | 100,000 | $0.57 | $57,320.00 | 44% 225.88K to 325.88K | (2%) |
| 08-Dec-21 5:14 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Dec-21 | Payment of Exercise | 225 | $0.72 | $162.00 | (< 1%) 226.1K to 225.88K | (< 1%) |
| 02-Dec-21 6:31 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Nov-21 | Payment of Exercise | 107 | $0.78 | $83.46 | (< 1%) 226.21K to 226.1K | 9% |
| 09-Nov-21 5:38 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Nov-21 | Payment of Exercise | 225 | $1.33 | $299.25 | (< 1%) 226.44K to 226.21K | 2% |
| 01-Nov-21 7:51 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Oct-21 | Payment of Exercise | 107 | $1.15 | $123.05 | (< 1%) 226.54K to 226.44K | 0% |
| 08-Oct-21 4:39 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Oct-21 | Payment of Exercise | 225 | $1.08 | $243.00 | (< 1%) 226.77K to 226.54K | (4%) |
| 04-Oct-21 4:14 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Sep-21 | Payment of Exercise | 107 | $1.19 | $127.33 | (< 1%) 226.88K to 226.77K | 0% |
| 15-Sep-21 8:00 PM View: | Nabriva Therapeutics Plc (NBRV) | 14-Sep-21 | Market Purchase | 50,000 | $1.13 | $56,500.00 | 28% 176.88K to 226.88K | (4%) |
| 08-Sep-21 5:27 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Sep-21 | Payment of Exercise | 225 | $1.11 | $249.75 | (< 1%) 177.1K to 176.88K | 3% |
| 10-Aug-21 5:16 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Aug-21 | Payment of Exercise | 225 | $1.17 | $263.25 | (< 1%) 177.43K to 177.21K | 3% |
| 03-Aug-21 4:09 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jul-21 | Payment of Exercise | 107 | $1.10 | $117.70 | (< 1%) 177.54K to 177.43K | (5%) |
| 08-Jul-21 4:11 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jul-21 | Payment of Exercise | 225 | $1.27 | $285.75 | (< 1%) 177.76K to 177.54K | 5% |
| 08-Jun-21 4:10 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jun-21 | Payment of Exercise | 225 | $1.34 | $301.50 | (< 1%) 178.1K to 177.87K | (5%) |
| 02-Jun-21 4:12 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-May-21 | Payment of Exercise | 107 | $1.38 | $147.66 | (< 1%) 178.2K to 178.1K | (< 1%) |
| 10-May-21 5:53 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-May-21 | Payment of Exercise | 225 | $1.49 | $335.25 | (< 1%) 178.43K to 178.2K | 1% |
| 04-May-21 4:03 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Apr-21 | Payment of Exercise | 107 | $1.78 | $190.46 | (< 1%) 178.53K to 178.43K | 3% |
| 08-Apr-21 9:48 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Apr-21 | Payment of Exercise | 225 | $1.73 | $389.25 | (< 1%) 178.76K to 178.53K | 3% |
| 02-Apr-21 6:11 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Mar-21 | Payment of Exercise | 107 | $1.66 | $177.62 | (< 1%) 181.79K to 181.68K | (5%) |
| 08-Apr-21 9:48 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Mar-21 | Payment of Exercise | 225 | $1.79 | $402.75 | (< 1%) 178.99K to 178.76K | 6% |
| 02-Mar-21 7:42 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Feb-21 | Payment of Exercise | 106 | $2.39 | $253.34 | (< 1%) 181.89K to 181.79K | 20% |
| 08-Apr-21 9:48 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Feb-21 | Payment of Exercise | 2,695 | $2.90 | $7,815.50 | (1%) 181.68K to 178.99K | 42% |
| 02-Feb-21 8:01 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jan-21 | Payment of Exercise | 125 | $2.62 | $327.50 | (< 1%) 182.02K to 181.89K |